Literature DB >> 10904188

Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans.

H S Oz1, W T Hughes.   

Abstract

Recent studies suggest that Pneumocystis carinii DNA may be detected by PCR in oropharyngeal secretions in the majority of patients with P. carinii pneumonitis (PCP). However, the prevalence of P. carinii DNA in patients without PCP has not been well established. A prospective study of 258 nasal, pharyngeal, and salivary specimens from 86 individuals with AIDS, cancer or no underlying disease, and without respiratory infection, found no P. carinii DNA in any of the samples. Separately, to validate the PCR for detection of P. carinii DNA, 45 specimens from the lower respiratory tract (bronchoalveolar lavage [BAL] and sputum) from 31 patients with pneumonitis and AIDS or cancer were studied. Eleven had PCP by conventional stains and 20 did not. All patients with PCP, and none without PCP, had P. carinii DNA in BAL, sputum or both. The study indicates the prevalence of P. carinii DNA is low or absent in oropharyngeal secretions in the absence of PCP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904188     DOI: 10.1016/s0732-8893(00)00146-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

1.  Collection of nasal secretions for immunological analysis.

Authors:  Jean-Baptiste Watelet; Philippe Gevaert; Gabriele Holtappels; Paul Van Cauwenberge; Claus Bachert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

2.  Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia.

Authors:  Hans Henrik Larsen; Henry Masur; Joseph A Kovacs; Vee J Gill; Victoria A Silcott; Palaniandy Kogulan; Janine Maenza; Margo Smith; Daniel R Lucey; Steven H Fischer
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs.

Authors:  C R Icenhour; S L Rebholz; M S Collins; M T Cushion
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity.

Authors:  John W Wilson; Andew H Limper; Thomas E Grys; Theresa Karre; Nancy L Wengenack; Matthew J Binnicker
Journal:  Diagn Microbiol Infect Dis       Date:  2011-02       Impact factor: 2.803

Review 6.  Advances in the diagnosis of fungal pneumonias.

Authors:  Bryan T Kelly; Kelly M Pennington; Andrew H Limper
Journal:  Expert Rev Respir Med       Date:  2020-04-21       Impact factor: 3.772

7.  Use of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.

Authors:  Jonathan J Juliano; Eric Barnett; Christian M Parobek; Steve M Taylor; Steven R Meshnick; Stephen Stone; Emily Chang; Serena Fong; Laurence Huang
Journal:  Open Forum Infect Dis       Date:  2015-06-03       Impact factor: 3.835

8.  Detection of Pneumocystis in the nasal swabs of immune-suppressed rats by use of PCR and microscopy.

Authors:  Hüseyin Can; Ayşe Caner; Mert Döşkaya; Aysu Değirmenci; Sabire Karaçalı; Ceylan Polat; Yüksel Gürüz; Ahmet Uner
Journal:  Med Sci Monit Basic Res       Date:  2013-02-13

9.  Pregnancy and asymptomatic carriage of Pneumocystis jiroveci.

Authors:  Sergio L Vargas; Carolina Angelica Ponce; Catherine Andrea Sanchez; Ana Victoria Ulloa; Rebeca Bustamante; Guido Juarez
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

10.  Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study.

Authors:  Jannik Helweg-Larsen; Jørgen Skov Jensen; Birthe Dohn; Thomas L Benfield; Bettina Lundgren
Journal:  BMC Infect Dis       Date:  2002-11-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.